國際人工器官雜志（IJAO）是歐洲人工器官學會（ESAO）的官方雜志。《國際人工器官雜志》（IJAO）發表同行評審的研究和臨床、實驗和理論，對人工、生物人工和組織工程器官領域的貢獻。IJAO的任務是促進人工、生物人工和組織工程器官的開發和優化，用于植入或在手術中使用，以治療所有人體組織和器官的功能缺陷。感興趣的主題范圍從最初的概念到臨床應用，并分為以下獨立的部分，由高素質的編輯管理：失血、透析和肝臟支持約阿希姆·揚科夫斯基，德國亞琛大學醫院，亞琛，德國安東尼奧·桑托羅，意大利博洛尼亞圣奧索拉-馬爾皮吉小兒麻痹癥診所本節重點介紹使用膜或吸附劑的血液解毒過程的裝置和程序，例如血液透析、血液過濾、血液透析、血漿置換、免疫性血漿置換、白細胞置換，以及血漿采購和血漿衍生物制備過程。本節包括血液解毒和支持肝代謝衰竭的系統。心臟輔助裝置和人工心臟史蒂芬·喬布斯，烏茲魯文，勒文，比利時意大利維羅納特倫托鎮醫院，阿爾多·米蘭本節介紹左心室輔助裝置、經心尖旁路、體外心臟輔助裝置、全人工心臟、瓣膜植入物、血管假體以及器官灌注設備和技術。人工肺、ECMO和呼吸支持德國亞琛烏克林克亞琛Rwth Aachen Khosrow Mottaghy比利時根特根特大學Filip de Somer本節重點介紹治療急慢性呼吸衰竭的假體和程序、ECMO系統的開發和臨床應用。感覺器官和神經刺激曼弗雷德·比杰克，奧地利維也納醫學大學本節涵蓋人工和生物人工組織和器官，以替換/糾正感官缺陷（如耳、眼等），以及神經和中樞神經系統刺激。組織工程、生物人工器官和再生醫學曼努埃拉·雷蒙迪，米蘭政治中心，意大利米蘭Dimitrios Stamatialis，荷蘭恩施德特溫特大學本節重點介紹生物工程組織和器官的發展、特征和使用，以及研究和促進組織或器官自再生的技術，包括細胞療法。生物材料與納米技術英國利物浦大學約翰·亨特Joerg Vienken，德國Usingen生物科學公司本節論述了合成材料和天然材料的開發、制造、改性和表征，這些材料具有納米級的受控性能，使其能夠接觸體液和細胞，用于修復和治療應用。個性化醫療和個性化護理德國漢諾威清真寺診斷與治療公司Harald Mischak美國路易斯維爾大學邁克爾·布賴爾本節介紹了病理條件的基因組學、蛋白質組學、代謝組學和計算特征，以及如何將這些信息用于基于人工、生物人工和組織工程器官的定制治療。機械假肢、機器人和醫療技術Marcel Rutten，荷蘭埃因霍溫理工大學本節論述了機械假體和機器人系統的開發和臨床應用，以及新出現的醫療技術，以幫助器官或組織衰竭、需要康復和疾病預防的患者。

The International Journal of Artificial Organs (IJAO) is the Official Journal of the European Society for Artificial Organs (ESAO).The International Journal of Artificial Organs (IJAO) publishes peer-reviewed research and clinical, experimental and theoretical, contributions to the field of artificial, bioartificial and tissue-engineered organs. The mission of the IJAO is to foster the development and optimization of artificial, bioartificial and tissue-engineered organs, for implantation or use in procedures, to treat functional deficits of all human tissues and organs.The topics of interest range from the initial concept to clinical application, and are grouped in the following independent sections managed by highly qualified Editors:Apheresis, dialysis and liver supportJoachim Jankowski, Uniklinik RWTH Aachen, Aachen, GermanyAntonio Santoro, Policlinico Sant'Orsola-Malpighi, Bologna, ItalyThis section focuses on devices and procedures for blood detoxification processes using membranes or sorbents, such as hemodialysis, hemofiltration, hemodiafiltration, plasmapheresis, immune apheresis, leukoapheresis, and processes for plasma procurement and the preparation of plasma derivatives. The section includes systems for blood detoxification and support of liver metabolic failure..Cardiac assist devices and artificial heartSteven Jacobs, UZ Leuven, Leuven, BelgiumAldo Domenico Milano, Ospedale Borgo Trento, Verona, ItalyThis section deals with left ventricular assist devices, trans-apical by-pass, extracorporeal heart assist devices, total artificial heart, valve implants, vascular prostheses, and organ perfusion equipment and techniques.Artificial lung, ECMO and respiratory supportKhosrow Mottaghy, Uniklinik RWTH Aachen, Aachen, GermanyFilip De Somer, Ghent University, Ghent, BelgiumThis section focuses on prostheses and procedures for the treatment of acute and chronic respiratory failure, development and clinical use of ECMO systems.Sensory organs and neural stimulationManfred Bijak, Medical University of Vienna, Vienna, AustriaThis section covers artificial and bioartificial tissues and organs to replace/correct sensory deficits (e.g., ear, eye etc.), as well as nerve and central nervous system stimulation.Tissue engineering, bioartificial organs and regenerative medicineManuela Raimondi, Politecnico di Milano, Milano, ItalyDimitrios Stamatialis, University of Twente, Enschede, The NetherlandsThis section focuses on the development, characterization and use of bioengineered tissues and organs, and on techniques to investigate and promote tissue or organ self-regeneration including cell therapies.Biomaterials and nanotechnologyJohn Hunt, University of Liverpool, Liverpool, UKJoerg Vienken, Biosciences, Usingen, GermanyThis section deals with the development, manufacturing, modification, and characterization of synthetic and natural materials with controlled properties, down to the nanometer scale, that make them capable of contacting body fluids and cells for prosthetic and therapeutic applications.Personalized medicine and individualized careHarald Mischak, Mosaiques Diagnostic and Therapeutics AG, Hannover, GermanyMichael Brier, University of Louisville, USAThis section covers genomic, proteomic, metabolomic and computational characterization of pathological conditions, and on how this information may be used to custom tailored treatments based on artificial, bioartificial and tissue engineered organs.Mechanical prostheses, robotics and medical technologyMarcel Rutten, TU/e University of Technology, Eindhoven, The NetherlandsThis section deals with the development and clinical use of mechanical prostheses and robotic systems, as well with new and emerging medical technologies for assistance of patients with organ or tissue failure, in need of rehabilitation and disease prevention.